Position
Chief Medical Officer
Company
GeNeuro
GenevaBiotechnologyHealth CarePharmaceuticalDescription
GeNeuro, a leading biopharmaceutical company specializing in treatments for neurological and autoimmune diseases, has announced the appointment of Anke Post as Chief Medical Officer. Anke will bring her extensive experience and expertise to drive the company's clinical development programs forward.
Quick answer
GeNeuro Appoints Anke Post as Chief Medical Officer (April 6, 2024). GeNeuro is based in Geneva, Geneva, Switzerland.
- Who is the new Chief Medical Officer at GeNeuro?
- GeNeuro named Anke Post Chief Medical Officer, announced April 6, 2024.
- What did GeNeuro announce on April 6, 2024?
- GeNeuro, a leading biopharmaceutical company specializing in treatments for neurological and autoimmune diseases, has announced the appointment of Anke Post as Chief Medical Officer. Anke will bring her extensive experience and expertise to drive the company's clinical development programs forward.
- What does GeNeuro do?
- GeNeuro‘s mission is to develop safe and effective treatments against neurological disorders and autoimmune diseases, such as MS, ALS and PASC, by neutralizing pathogenic proteins encoded by HERVs, which represent 8% of...
- Where is GeNeuro based?
- GeNeuro is based in Geneva, Geneva, Switzerland.
- Which similar companies made leadership changes around the same time?
- Stevanato Group (April 4, 2024), Lupin (April 4, 2024), Ligand Pharmaceuticals Incorporated (April 3, 2024) and Acadia Pharmaceuticals (April 2, 2024) also announced leadership changes within 45 days of GeNeuro.
Source: Fundz verified event record.
Other recent leadership changes in Pharmaceutical and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Stevanato Group Appoints Ugo Gay as Chief Operations Officer (April 4, 2024)
- Lupin Appoints Dr. Ranjana Pathak as Chief Quality Officer, Succeeding Johnny Mikell (April 4, 2024)
- Ligand Pharmaceuticals Launches Pelthos Therapeutics and Appoints Scott Plesha as Chief Executive Officer (April 3, 2024)
- Acadia Pharmaceuticals Appoints Dr. Elizabeth H. Z. Thompson as Executive Vice President, Head of Research and Development (April 2, 2024)
- PharmaCord Names Cindy Padgett as Chief Commercial Officer (April 10, 2024)
- Petauri Appoints Dan Vanderpoel as Executive Vice President, Strategic Payer Marketing and Head, Client Solutions (April 2, 2024)
Who to call at GeNeuro, and when
A new leader at GeNeuro brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day GeNeuro raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at GeNeuro, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at GeNeuro. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment GeNeuro changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
GeNeuro changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.